Obesity
Showing NaN - NaN of 53
Type 2 Diabetes, Obesity, Overweight Trial in Worldwide (Retatrutide, Placebo)
Not yet recruiting
- Type 2 Diabetes
- +3 more
- Retatrutide
- Placebo
-
Los Angeles, California
- +91 more
Jul 10, 2023
Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Overweight
- Obesity
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +804 more
Dec 19, 2022
Obesity Trial in United States
Recruiting
- Obesity
-
Marina Del Rey, California
- +15 more
Oct 3, 2022
Overweight, Obesity Trial in Worldwide (Gelesis100, )
Completed
- Overweight
- Obesity
- Gelesis100
- placebo
-
Anaheim, California
- +35 more
Aug 8, 2022
B-cell Acute Lymphoblastic Leukemia, Obesity Trial in United States (IDEAL2 Intervention)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- Obesity
- IDEAL2 Intervention
-
Los Angeles, California
- +15 more
Jun 23, 2022
Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Obesity
- Semaglutide
- Placebo (semaglutide)
-
Fairhope, Alabama
- +97 more
Jun 15, 2022
Obesity, Hypertension, Hyperlipidemias Trial in Cincinnati (In-store POP education, Online POP education)
Completed
- Obesity
- +3 more
- In-store POP education
- Online POP education
-
Cincinnati, OhioUniversity of Cincinnati Medical Center - UC Health
Feb 18, 2022
Overweight, Obesity Trial in United States
Recruiting
- Overweight
- Obesity
-
Little Rock, Arkansas
- +27 more
Feb 11, 2022
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (Semaglutide, Placebo)
Completed
- Metabolism and Nutrition Disorder
- Obesity
- Semaglutide
- Placebo
-
Anniston, Alabama
- +71 more
Jan 7, 2022
Obesity, Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver Disease Trial in Cincinnati (Comprehensive Lifestyle
Completed
- Obesity
- +2 more
- Comprehensive Lifestyle Intervention
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Nov 1, 2021
Obesity Trial in Cincinnati (Telehealth Encounter)
Completed
- Obesity
- Telehealth Encounter
-
Cincinnati, IndianaCincinnati Children's Hospital Medical Center
Feb 1, 2021
Obesity Trial in Cincinnati (Group nutrition sessions, Fitbit)
Completed
- Obesity
- Group nutrition sessions
- Fitbit
-
Cincinnati, OhioPediatric Primary Care Center (PPC) Cincinnati Children's Hospit
Nov 13, 2020
Overweight, Diabetes, PreDiabetes Trial in Worldwide (Gelesis200, Placebo)
Unknown status
- Overweight
- +3 more
- Gelesis200
- Placebo
-
Birmingham, Alabama
- +29 more
Jul 20, 2020
ORBERA™ Post-Approval Study
Completed
- Obesity
- Overweight
-
Little Rock, Arkansas
- +10 more
Jul 9, 2020
Obalon Balloon System Post-Approval Study
Unknown status
- Obesity
- Obalon Balloon System
-
Fountain Valley, California
- +14 more
Apr 29, 2020
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (semaglutide, liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- semaglutide
- +2 more
-
Anaheim, California
- +73 more
Apr 14, 2020
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
A Prospective Multicenter Post Approval Study of ReShape™
Unknown status
- Obesity
- Reshape Integrated Dual Balloon
-
Dothan, Alabama
- +13 more
Mar 28, 2019
Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States
Unknown status
- Endometrial Clear Cell Adenocarcinoma
- +6 more
- 3-Dimensional Conformal Radiation Therapy
- +7 more
-
Birmingham, Alabama
- +539 more
Mar 8, 2019
A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study
Terminated
- Obesity
- Overweight
-
Fountain Valley, California
- +10 more
Jun 25, 2018
Obesity Trial in United States (S-2367 Placebo, S-2367 1600 mg q.d. 54 Weeks, S-2367 1600 mg q.d. 60 weeks)
Completed
- Obesity
- S-2367 Placebo
- +4 more
-
Birmingham, Alabama
- +39 more
May 9, 2018